J&J's Darzalex received regulatory approval in Europe and the United States following review of TRIANGLE study data.
1 report, 0 independent
Updated Jun 23
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
J&J's Darzalex received regulatory approval in Europe and the United States following review of TRIANGLE study data.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
- FDA
-
Johnson & Johnson
U.S multinational medical devices, pharmaceutical and consumer packaged goods manufacturer
-
Europe
terrestrial continent located in north-western Eurasia
Related events
- Arise is seeking FDA approval for a drug as of October 7, 2026.
- Generic medicine services are seeking approval for launch from the FDA.
- FDA approval boosts the Korean drug industry, driving market attention for companies like SamChunDang Pharm.
- Both the FDA and the European Medicines Agency govern drug approval processes.
- A company is conducting clinical trials and seeking drug approval for the U.S. market under the FDA.
Coverage
Newest first; wire copies grouped- Unknown outlet